The U.S. Food and Drug Administration (FDA) has approved Acuvue Abiliti Overnight Therapeutic Lenses (Johnson & Johnson Vision), according to a press release. This is the first and only FDA approved orthokeratology contact lens for the management of myopia.
“The FDA approval of Abiliti Overnight marks an important milestone in our commitment to help change the trajectory of eye health and reshape the future of children with myopia,” said Xiao-Yu Song, MD, PhD, Global Head of Research & Development, Johnson & Johnson Vision in the press release. “We look forward to supporting parents and eye care professionals in their care of children with comprehensive resources, starting with Abiliti™ Overnight Therapeutic Lenses, and continuing with additional products and services to address the progression of myopia.”
Read the full press release here.